Bluegrass Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bluegrass Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,000	Closed	-$3.71M	–	12
2024 Q3	$3.71M	Sell	6,000 -9,000	-60%	-$5.33M	3.39%	12
2024 Q2	$8.29M	Sell	15,000 -1,000	-6%	-$573K	8.48%	6
2024 Q1	$9.3M	Sell	16,000 -500	-3%	-$281K	9.69%	5
2023 Q4	$8.76M	Buy	16,500 +4,500	+38%	+$2.18M	10.35%	4
2023 Q3	$6.07M	Hold	12,000	–	–	7.37%	8
2023 Q2	$6.26M	Buy	12,000 +2,000	+20%	+$1.08M	6.76%	8
2023 Q1	$5.76M	Hold	10,000	–	–	6.4%	8
2022 Q4	$5.51M	Sell	10,000 -2,000	-17%	-$1.06M	6.85%	9
2022 Q3	$6.09M	Buy	+12,000	New	+$6.72M	6.01%	9

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bluegrass Capital Partners's TMO Position: Q4 2024 in Review

Bluegrass Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 6,000 shares — an estimated $3.71M sold.

Bluegrass Capital Partners first reported a position in TMO in Q3 2022 and held it in 9 quarters. The position peaked at $9.3M in Q1 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Bluegrass Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Bluegrass Capital Partners sold 6,000 Thermo Fisher Scientific shares in Q4 2024, an estimated $3.71M.
Bluegrass Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2022 and held it in 9 quarters.
Bluegrass Capital Partners's Thermo Fisher Scientific position peaked at $9.3M in Q1 2024.
2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Bluegrass Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.